Please assess the completion status of the following clinical trial:

Trial Title: Ethanol Locks for the Treatment of Central Venous Line Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 6 months-23 years~* documented central line infection with bacteria or fungus (positive blood culture)~Exclusion Criteria:~* allergy or intolerance to ethanol~* pregnant or breastfeeding~* central line tunnel or exit site infection

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 23 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): 70% ethanol lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. 70% ethanol solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.
- 2 (Type: PLACEBO_COMPARATOR): heparin flush 10 units/ml lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. heparin flush solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.

Based on this trial design, predict the completion outcome and termination type (if applicable).